Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccination for asthma exacerbations.

P G Bardin1

  • 1Department of Respiratory and Sleep Medicine, Monash Medical Centre, Melbourne, Victoria, Australia. p.bardin@southernhealth.org.au

Internal Medicine Journal
|July 2, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abnormal vocal cord movement in patients with and without airway obstruction and asthma symptoms.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016
Same author

Vocal cord dysfunction: asking the right questions.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2015
Same author

What's in a name? Expiratory tracheal narrowing in adults explained.

Clinical radiology·2013
Same author

Hygiene hypothesis, allergy and BCG: a dirty mix?

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2008
Same author

Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.

Allergy·2007
Same author

Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge.

Respiration; international review of thoracic diseases·2006
Same journal

The paradox of peer review: protecting science or policing thought?

Internal medicine journal·2026
Same journal

Immune-related pancytopenia in pregnancy.

Internal medicine journal·2026
Same journal

Crossover effect: causal machine learning reveals opposing mortality responses to mean arterial pressure targets among phenotypically distinct hypertensive patients with septic shock.

Internal medicine journal·2026
Same journal

Clinicopathological findings, correlations and outcomes in patients with renal disease and living with antiretroviral-treated human immunodeficiency virus infection.

Internal medicine journal·2026
Same journal

Approach to thyroid disorders associated with immune checkpoint inhibitors and tyrosine kinase inhibitors.

Internal medicine journal·2026
Same journal

A scoping review of specialist hypertension clinics.

Internal medicine journal·2026
See all related articles

Most asthma exacerbations stem from common cold virus infections, primarily rhinovirus. Vaccines may not prevent these infections but could reduce asthma severity by inducing cross-reactive antibodies against rhinovirus.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Virology

Background:

  • Asthma exacerbations are frequently triggered by viral respiratory infections.
  • Rhinoviruses are the most common cause of common colds and asthma exacerbations.

Purpose of the Study:

  • To explore the potential of vaccine-induced cross-reactive antibodies in mitigating rhinovirus-associated asthma exacerbations.
  • To investigate the role of antibody responses in rhinovirus infections and their impact on airway inflammation.

Main Methods:

  • The study proposes a hypothesis based on existing immunological principles of antibody responses.
  • Analysis of antibody-mediated protection against rhinovirus serotypes and their effect on respiratory symptoms.

Main Results:

Related Experiment Videos

  • Serum neutralizing antibodies provide complete protection against homologous rhinovirus serotypes.
  • Cross-reactive antibodies offer partial protection, leading to milder cold and airway symptoms.

Conclusions:

  • Vaccine-induced cross-reactive antibodies may not prevent rhinovirus infections.
  • Such antibodies could potentially reduce the severity of asthma exacerbations and associated airway symptoms.